Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPNA5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SEC31A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | EEF1E1-BLOC1S5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PCM1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FAM174A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | FAM159B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SPHK2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RNF14 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | DICER1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |